Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

Trump's second term has included pauses to HIV public awareness campaigns and the cancellation of at least 20 grants funding ...

Carl Schmid, the executive director of the HIV+Hepatitis Policy Institute in Washington, told Reuters he had been told by a ...